filings.toolsItem 16. Form 10-K Summary
23K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
None.
Ameriprise Financial, Inc.
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AMERIPRISE FINANCIAL, INC.
Registrant
| Date: | February 20, 2025 | By | /s/ Walter S. Berman | ||||||||
| Walter S. Berman Executive Vice President and Chief Financial Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.
| Date: | February 20, 2025 | By | /s/ James M. Cracchiolo | ||||||||
| James M. Cracchiolo Chairman and Chief Executive Officer (Principal Executive Officer and Director) |
| Date: | February 20, 2025 | By | /s/ Walter S. Berman | ||||||||
| Walter S. Berman Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
| Date: | February 20, 2025 | By | /s/ Dawn M. Brockman | ||||||||
| Dawn M. Brockman Senior Vice President and Controller (Principal Accounting Officer) |
| Date: | February 20, 2025 | By | /s/ Dianne Neal Blixt* | ||||||||
| Dianne Neal Blixt Director |
| Date: | February 20, 2025 | By | /s/ Amy DiGeso* | ||||||||
| Amy DiGeso Director |
| Date: | February 20, 2025 | By | /s/ Armando Pimentel, Jr.* | ||||||||
| Armando Pimentel, Jr. Director |
| Date: | February 20, 2025 | By | /s/ Robert F. Sharpe, Jr.* | ||||||||
| Robert F. Sharpe, Jr. Director |
| Date: | February 20, 2025 | By | /s/ Brian T. Shea* | ||||||||
| Brian T. Shea Director |
| Date: | February 20, 2025 | By | /s/ W. Edward Walter III* | ||||||||
| W. Edward Walter III Director |
Ameriprise Financial, Inc.
| Date: | February 20, 2025 | By | /s/ Christopher J. Williams* | ||||||||
| Christopher J. Williams Director |
| *By | /s/ Walter S. Berman | ||||
| Walter S. Berman Executive Vice President and Chief Financial Officer |
*Walter S. Berman, by signing his name hereto on the 20th day of February, 2025 does hereby sign this document pursuant to powers of attorney duly executed by the Directors named, filed with the Securities and Exchange Commission on behalf of such Directors as Exhibit 24 to this Form 10-K, all in the capacities and on the date stated, such persons being the majority of the Directors of the Registrant.
Ameriprise Financial, Inc.
Schedule I - Condensed Financial Information of Registrant
(Parent Company Only)
Ameriprise Financial, Inc.
| Schedule I — Condensed Financial Information of Registrant Condensed Statements of Operations (Parent Company Only) | |||||||||||||||||
| Years Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Revenues | |||||||||||||||||
| Net investment income | $ | 94 | $ | 77 | $ | 16 | |||||||||||
| Other revenues | 11 | 5 | 6 | ||||||||||||||
| Total revenues | 105 | 82 | 22 | ||||||||||||||
| Banking and deposit interest expense | 35 | 35 | 8 | ||||||||||||||
| Total net revenues | 70 | 47 | 14 | ||||||||||||||
| Expenses | |||||||||||||||||
| Distribution expenses | 61 | 46 | 4 | ||||||||||||||
| Interest and debt expense | 144 | 138 | 104 | ||||||||||||||
| General and administrative expense | 328 | 306 | 265 | ||||||||||||||
| Total expenses | 533 | 490 | 373 | ||||||||||||||
| Pretax loss before equity in earnings of subsidiaries | (463) | (443) | (359) | ||||||||||||||
| Income tax provision | 182 | 142 | 139 | ||||||||||||||
| Loss before equity in earnings of subsidiaries | (645) | (585) | (498) | ||||||||||||||
| Equity in earnings of subsidiaries, net of tax | 4,046 | 3,141 | 3,647 | ||||||||||||||
| Net income | 3,401 | 2,556 | 3,149 | ||||||||||||||
| Other comprehensive income (loss), net of tax | (142) | 780 | (1,904) | ||||||||||||||
| Total comprehensive income (loss) | $ | 3,259 | $ | 3,336 | $ | 1,245 |
See Notes to Condensed Financial Information of Registrant.
Ameriprise Financial, Inc.
| Schedule I — Condensed Financial Information of Registrant Condensed Balance Sheets (Parent Company Only) | |||||||||||
| December 31, | |||||||||||
| 2024 | 2023 | ||||||||||
| (in millions, except share amounts) | |||||||||||
| Assets | |||||||||||
| Cash and cash equivalents | $ | 844 | $ | 519 | |||||||
| Investments | 921 | 841 | |||||||||
| Loans to subsidiaries | 343 | 489 | |||||||||
| Due from subsidiaries | 273 | 246 | |||||||||
| Receivables | 26 | 49 | |||||||||
| Land, buildings, equipment, and software, net of accumulated depreciation of $779 and $791, respectively | 303 | 265 | |||||||||
| Investments in subsidiaries | 6,910 | 6,974 | |||||||||
| Other assets | 1,605 | 1,580 | |||||||||
| Total assets | $ | 11,225 | $ | 10,963 | |||||||
| Liabilities and Equity | |||||||||||
| Liabilities: | |||||||||||
| Accounts payable and accrued expenses | $ | 1,422 | $ | 1,229 | |||||||
| Due to subsidiaries | 347 | 347 | |||||||||
| Borrowings from subsidiaries | 756 | 580 | |||||||||
| Long-term debt | 2,842 | 3,398 | |||||||||
| Other liabilities | 630 | 680 | |||||||||
| Total liabilities | 5,997 | 6,234 | |||||||||
| Equity: | |||||||||||
| Common shares ($0.01 par value; shares authorized, 1,250,000,000; shares issued, 337,729,050 and 336,780,893, respectively) | 3 | 3 | |||||||||
| Additional paid-in capital | 10,141 | 9,824 | |||||||||
| Retained earnings | 24,713 | 21,905 | |||||||||
| Treasury shares, at cost (241,562,357 and 236,607,681 shares, respectively) | (27,721) | (25,237) | |||||||||
| Accumulated other comprehensive income (loss), net of tax, including amounts applicable to equity investments in subsidiaries | (1,908) | (1,766) | |||||||||
| Total equity | 5,228 | 4,729 | |||||||||
| Total liabilities and equity | $ | 11,225 | $ | 10,963 |
See Notes to Condensed Financial Information of Registrant.
Ameriprise Financial, Inc.
| Schedule I — Condensed Financial Information of Registrant Condensed Statements of Cash Flows (Parent Company Only) | |||||||||||||||||
| Years Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| (in millions) | |||||||||||||||||
| Cash Flows from Operating Activities | |||||||||||||||||
| Net income | $ | 3,401 | $ | 2,556 | $ | 3,149 | |||||||||||
| Equity in earnings of subsidiaries | (4,046) | (3,141) | (3,647) | ||||||||||||||
| Dividends received from subsidiaries | 3,731 | 3,025 | 2,512 | ||||||||||||||
| Other operating activities, primarily with subsidiaries | 422 | 453 | 226 | ||||||||||||||
| Net cash provided by (used in) operating activities | 3,508 | 2,893 | 2,240 | ||||||||||||||
| Cash Flows from Investing Activities | |||||||||||||||||
| Available-for-Sale securities: | |||||||||||||||||
| Proceeds from sales | — | 4 | — | ||||||||||||||
| Maturities, sinking fund payments and calls | 55 | 43 | 153 | ||||||||||||||
| Purchases | (128) | (38) | (124) | ||||||||||||||
| Proceeds from sales of other investments | — | — | 7 | ||||||||||||||
| Purchase of other investments | — | (10) | (1) | ||||||||||||||
| Purchase of land, buildings, equipment and software | (59) | (87) | (70) | ||||||||||||||
| Contributions to subsidiaries | (145) | (324) | (743) | ||||||||||||||
| Return of capital from subsidiaries | 351 | — | 207 | ||||||||||||||
| Repayment of loans to subsidiaries | 3,406 | 1,992 | 1,960 | ||||||||||||||
| Issuance of loans to subsidiaries | (3,260) | (2,232) | (1,726) | ||||||||||||||
| Other, net | (1) | 2 | — | ||||||||||||||
| Net cash provided by (used in) investing activities | 219 | (650) | (337) | ||||||||||||||
| Cash Flows from Financing Activities | |||||||||||||||||
| Dividends paid to shareholders | (574) | (550) | (534) | ||||||||||||||
| Repurchase of common shares | (2,448) | (2,127) | (1,978) | ||||||||||||||
| Issuance of long-term debt, net of issuance costs | — | 1,335 | 495 | ||||||||||||||
| Repayments of long-term debt | (561) | (760) | (510) | ||||||||||||||
| Borrowings from subsidiaries | 726 | 1,003 | 1,210 | ||||||||||||||
| Repayments of borrowings from subsidiaries | (586) | (951) | (1,034) | ||||||||||||||
| Other, net | 41 | (35) | (18) | ||||||||||||||
| Net cash provided by (used in) financing activities | (3,402) | (2,085) | (2,369) | ||||||||||||||
| Net increase (decrease) in cash and cash equivalents | 325 | 158 | (466) | ||||||||||||||
| Cash and cash equivalents at beginning of period | 519 | 361 | 827 | ||||||||||||||
| Cash and cash equivalents at end of period | $ | 844 | $ | 519 | $ | 361 | |||||||||||
| Supplemental Disclosures: | |||||||||||||||||
| Interest paid on debt | $ | 148 | $ | 129 | $ | 98 | |||||||||||
| Income taxes paid, net | 179 | 233 | 91 | ||||||||||||||
| Non-cash dividends from subsidiaries | — | 77 | — | ||||||||||||||
See Notes to Condensed Financial Information of Registrant.
Ameriprise Financial, Inc.
Schedule I — Condensed Financial Information of Registrant
Notes to Condensed Financial Information of Registrant
(Parent Company Only)
1. Basis of Presentation
The accompanying Condensed Financial Statements include the accounts of Ameriprise Financial, Inc. (the “Parent Company”) and, on an equity basis, its subsidiaries and affiliates. The Condensed Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles. The financial information of the Parent Company should be read in conjunction with the Consolidated Financial Statements and Notes of Ameriprise Financial, Inc. and its subsidiaries (“Ameriprise Financial”). Parent Company revenues and expenses, other than interest and debt expense, are primarily related to intercompany transactions with subsidiaries and affiliates.
2. Investments
On December 23, 2020, RiverSource Life Insurance Company (“RiverSource Life”) issued a $500 million unsecured 3.5% surplus note due December 31, 2050 to the Parent Company. The surplus note is subordinate in right of payment to the prior payment in full of RiverSource Life’s obligations to policyholders, claimants and beneficiaries and all other creditors. No payment of principal or interest shall be made without the prior approval of the Minnesota Department of Commerce and such payments shall be made only from RiverSource Life’s statutory surplus. Interest payments, which commenced on June 30, 2021, are due semi-annually in arrears on June 30 and December 31. Subject to the preceding conditions, RiverSource Life may prepay all or a portion of the principal at any time. The held-to-maturity investment was $500 million as of both December 31, 2024 and 2023 and is recorded in Investments on the Parent Company’s Condensed Balance Sheets. For the years ended December 31, 2024, 2023 and 2022, interest income was $18 million and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.
In June of 2024, the Parent Company invested $69 million in an unrated residual tranche issued by Ameriprise Installment Financing, LLC, a subsidiary of the Parent Company. The residual tranche is collateralized by a portfolio of loans issued to advisors affiliated with Ameriprise Financial Services, LLC (“AFS”), a subsidiary of the Parent Company. As of December 31, 2024, the fair value of the residual tranche was $60 million and is reported in Investments on the Parent Company’s Condensed Balance Sheets. Interest income from the residual tranche was $2 million for the year ending December 31, 2024 and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.
In September of 2022, the Parent Company redeemed the outstanding unrated residual tranche issued by Ameriprise Advisor Financing, LLC (“AAF”), a subsidiary of the Parent Company, realizing a $23 million loss, and invested $30 million in a new unrated residual tranche issued by Ameriprise Advisor Financing 2, LLC (“AAF 2”). As of December 31, 2024 and 2023, the fair value of the residual tranche was $56 million and $30 million, respectively, and is reported in Investments on the Parent Company’s Condensed Balance Sheets. Interest income from the residual tranche was $7 million for the years ended December 31, 2024, 2023 and 2022 and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.
3. Debt
All of the debt of Ameriprise Financial is borrowings of the Parent Company, except as indicated below.
-
As of both December 31, 2024 and 2023, Ameriprise Financial had $201 million of borrowings from the Federal Home Loan Bank of Des Moines, which is primarily collateralized with commercial mortgage backed securities and residential mortgage backed securities.
-
As of December 31, 2024 and 2023, Ameriprise Financial debt included nil and $1 million, respectively, of other subsidiary lease obligations.
4. Borrowings from Subsidiaries
The Parent Company has intercompany lending arrangements with its subsidiaries. At the end of each business day, taking into consideration all legal and regulatory requirements associated with its subsidiaries, the Parent Company is entitled to draw on all funds in specified bank accounts. Repayment of all or a portion of the funds is due on demand. As of December 31, 2024 and 2023, the Company had $415 million and $375 million, respectively, available for repayment due on demand. The Parent Company also has revolving credit agreements with its subsidiaries as the borrower aggregating $1.3 billion as of both December 31, 2024 and 2023, of which $340 million and $205 million was outstanding as of December 31, 2024 and 2023, respectively.
5. Guarantees, Commitments and Contingencies
The Parent Company is the guarantor for operating leases of certain subsidiaries. All consolidated legal, regulatory and arbitration proceedings, including class actions of Ameriprise Financial are potential or current obligations of the Parent Company. The Parent Company has committed revolving credit agreements with its subsidiaries as the lender aggregating $363 million as of both December 31, 2024 and 2023, of which $99 million and $246 million was outstanding as of December 31, 2024 and 2023, respectively.
The Parent Company and Ameriprise Certificate Company (“ACC”) entered into a Capital Support Agreement on March 2, 2009, pursuant to which the Parent Company agrees to commit such capital to ACC as is necessary to satisfy applicable minimum capital requirements. Effective April 30, 2014, this agreement was amended to revise the maximum commitment to $50 million. For the years ended December 31, 2024, 2023 and 2022, ACC did not draw upon the Capital Support Agreement and had met all applicable capital requirements.
Ameriprise Financial, Inc.
AFS entered into a Financial Industry Regulatory Authority (“FINRA”) approved subordinated loan agreement with the Parent Company on December 15, 2014 for regulatory net capital purposes. The agreement consists of a $200 million secured demand note. The note is secured by cash and securities equal to the principal value of the note pledged by the Parent Company. As of both December 31, 2024 and 2023, AFS had not made a demand of the principal amount.
Ameriprise Enterprise Investment Services, Inc. (“AEIS”) entered into a FINRA approved subordinated loan agreement with the Parent Company on January 25, 2017 for regulatory net capital purposes. Under this agreement, AEIS borrowed $60 million from the Parent Company with an initial term of five years to be repaid no later than January 25, 2022. Both companies have the option to renew the agreement in one year-increments in perpetuity. The agreement was renewed in January 2022 and each year thereafter, extending the current maturity date to January 25, 2026.
6. Subsequent Events
The Parent Company made two $30 million cash contributions to Ameriprise Advisor Capital, LLC. The first occured on January 6, 2025 and the second occurred on January 27, 2025.
Previous: Item 15. Exhibits and Financial Statement Schedules